Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
10/2002
10/03/2002WO2001071004A3 Proteases
10/03/2002WO2001021812A9 Phosphatases which activate map kinase pathways
10/03/2002US20020143145 Detcting moduators of binding activity of preferential membrane proteins; obtain animal, incubate with modulator, monitor adjustment in activity from recptors
10/03/2002US20020143032 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/03/2002US20020143026 Induce mitotic arrest thereby making them useful as anti-cancer agents; also for therapy of diseases which can be treated by inducing mitotic arrest
10/03/2002US20020143020 Novel piperazine derivatives
10/03/2002US20020143004 Allosteric adenosine receptor modulators
10/03/2002US20020142436 Enzymatic protein for use in the treatment of tumors, nervous system, cardiovascular, psychological, pregnancy, bone, kidney, respiratory and alimentary canal disorders
10/03/2002US20020142353 Connective tissue growth factor (CTGF) and methods of use
10/03/2002US20020142045 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/03/2002US20020142008 Immunogenic pili presenting foreign peptides, their production and use
10/03/2002CA2442576A1 Bioactivity of methyl palmitate obtained from a mangrove plant salvadora persica l
10/03/2002CA2442178A1 2-amino-propanol derivatives
10/03/2002CA2441790A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002CA2441700A1 Polypeptides and nucleic acids for bolekine
10/03/2002CA2441599A1 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain
10/03/2002CA2441378A1 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
10/03/2002CA2441377A1 Protein phosphate inhibitors
10/03/2002CA2441092A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002CA2440676A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002CA2436198A1 Process for obtaining lignan, pharmaceutical compositions and uses thereof
10/02/2002EP1245676A1 Human monoclonal antibodies against tgf-beta ii receptor and medicinal use thereof
10/02/2002EP1245562A1 5-THIA-$g(v)-(SUBSTITUTED PHENYL)-PROSTAGLANDIN E ALCOHOLS, PROCESS FOR PREPARING THE ALCOHOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AS THE ACTIVE INGREDIENT
10/02/2002EP1245232A1 Oral solid preparation
10/02/2002EP1245231A2 Pharmaceutical formulations containing darifenacin
10/02/2002EP1244807A1 Il-6 like polynucleotide
10/02/2002EP1244790A2 Nucleic acids encoding polypeptides having chips activity
10/02/2002EP1244784A2 Methods and compositions for inhibiting neoplastic cell growth
10/02/2002EP1244693A1 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis
10/02/2002EP1244686A1 Transforming growth factor alpha hiii
10/02/2002EP1244685A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies
10/02/2002EP1244673A2 Novel imidazo 1,3,5]triazinones and the use thereof
10/02/2002EP1244672A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
10/02/2002EP1244669A1 Pyrazolopyrazines and their use as adenosine antagonists
10/02/2002EP1244657A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/02/2002EP1244649A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244628A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/02/2002EP1244626A2 Caspase inhibitors and uses thereof
10/02/2002EP1244621A1 Nitrile derivatives as cathepsin k inhibitors
10/02/2002EP1244620A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244619A1 Pyrrolidines which inhibit camp-specific pde
10/02/2002EP1244461A2 INHIBITION OF GSK-3$g(b)
10/02/2002EP1244455A1 Methods of treating vascular diseases characterized by nitric oxide insufficiency
10/02/2002EP1244350A2 Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal
10/02/2002EP0804196B1 Use of serotonin antagonists (5ht 3) for treating fibromyalgia
10/02/2002DE10114138A1 Cdk-inhibitorische Indirubinderivate mit erhöhter Löslichkeit Cdk-inhibitory indirubin derivatives with increased solubility
10/02/2002DE10112825A1 HESylierung von Wirkstoffen in wässriger Lösung HESylation of drugs in aqueous solution
10/02/2002DE10108122A1 Arzneimittel auf Basis von Tramadol Medicines based on tramadol
10/02/2002CN1372569A Keratinocyte growth factor-2
10/02/2002CN1372563A Oxathiepino [6,5-b] dihydropyridines, and related compositions and methods
10/02/2002CN1372559A Naphthyridine derivatives processes for their preparation their use and pharmaceutical compositions comprising them
10/02/2002CN1372555A Compositions and therapeutic mehtods involving isoflavones and analogues thereof
10/02/2002CN1372467A Improved topical medicaments and methods for photodynamic treatment of disease
10/02/2002CN1371745A Medicine for removing hernia
10/02/2002CN1371719A Smellting treated Chinese medicine
10/02/2002CN1371712A Medicine for treating uremia
10/02/2002CN1371685A Bladder irrigation original liquid
10/02/2002CN1091768C Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
10/02/2002CN1091766C Prenyl transferase inhibitors
10/02/2002CN1091604C Processed ginseng extract having enhanced pharmacological offset and preparation method
10/01/2002US6459003 Ether compounds
10/01/2002US6458963 Process for preparing eprosartan using regioselective protection of 2,4-disubstituted-imidazole intermediates
10/01/2002US6458951 For treatment of male erectile dysfunction, female sexual dysfunction
10/01/2002US6458846 Ion channel modulating agents
10/01/2002US6458845 Macrophage scavenger receptor antagonists
10/01/2002US6458837 Lipophilic diesters of chelating agents
10/01/2002US6458805 Antagonists; especially sodium salts
10/01/2002US6458801 Benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same
10/01/2002US6458796 Method of treating cardiovascular disorders, thromboembolic disorders and ischaemias, and urogenital system disorders, comprising administering to mammals
10/01/2002US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated
10/01/2002US6458775 NAALADase inhibitors useful as pharmaceutical compounds and compositions
10/01/2002US6458575 Useful in the diagnosis, prevention, and treatment of cancer, autoimmune/inflammatory disorders, and reproductive disorders; screening libraries of peptides and antibodies; purification; amino acid sequences
10/01/2002CA2228370C Piperazino derivatives as neurokinin antagonists
09/2002
09/30/2002CA2379791A1 Novel triazine compounds useful as sorbitol dehydrogenase inhibitors
09/27/2002CA2378876A1 Cyclohexylamine derivatives as subtype selective n-methyl-d-aspartate antagonists
09/26/2002WO2002074913A2 Nucleic acid-associated proteins
09/26/2002WO2002074773A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
09/26/2002WO2002074772A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors
09/26/2002WO2002074771A1 Tricyclic heterocyclic compound, process for producing the same, and use
09/26/2002WO2002074770A1 Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient
09/26/2002WO2002074767A1 Metalloproteinase inhibitors
09/26/2002WO2002074751A1 Metalloproteinase inhibitors
09/26/2002WO2002074748A1 Metalloproteinase inhibitors
09/26/2002WO2002074742A2 Cdk-inhibitory indirubin derivatives having an increased solubility
09/26/2002WO2002074733A2 Tryptase-inhibitors
09/26/2002WO2002074730A1 INHIBITORS OF INTEGRIN αvβ¿6?
09/26/2002WO2002074327A2 Compositions and methods for treating gonadotrophin related illnesses
09/26/2002WO2002074323A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
09/26/2002WO2002074318A1 Il-12 expression controlling agents
09/26/2002WO2002074312A1 Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors
09/26/2002WO2002074303A1 Amino acid compositions for ameliorating kidney failure
09/26/2002WO2002074292A2 Hormone replacement therapy
09/26/2002WO2002074249A2 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
09/26/2002WO2002074056A2 Allosteric adenosine receptor modulators
09/26/2002WO2002060900A3 Antagonists of mcp-1 function and methods of use thereof
09/26/2002WO2002055517A3 4-(hetero)aryl substituted indolinones
09/26/2002WO2002046214A3 Immunomodulatory protein derived from the yaba monkey tumor virus
09/26/2002WO2002000710A3 B7-like molecules and uses thereof
09/26/2002WO2001083775A3 Proteases
1 ... 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 ... 562